Article Details

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Expected to Announce Quarterly Sales of $279.51 ...

Retrieved on: 2021-05-18 06:42:32

Tags for this article:

Click the tags to see associated articles and topics

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Expected to Announce Quarterly Sales of $279.51 .... View article details on hiswai:

Excerpt

AQR Capital Management LLC now owns 42,091 shares of the company's stock valued at $4,086,000 after purchasing an additional 30,775 shares in ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up